Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: A longterm cohort study of 892 patients with viral cirrhosis

Journal of Gastroenterology

Volumn 38, Issue 9, 2003, Pages 865-876

  Ikeda, Kenji ^a,b   Arase, Yasuji ^a,b   Kobayashi, Masahiro ^a,b   Saitoh, Satoshi ^a,b   Someya, Takashi ^a,b   Hosaka, Tetsuya ^a,b   Suzuki, Yoshiyuki ^a,b   Suzuki, Fumitaka ^a,b   Tsubota, Akihito ^a,b   Akuta, Norio ^a,b   Kumada, Hiromitsu ^a,b  

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Intrahepatic metastasis; Multicentric carcinogenesis; Recurrence

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; ANTIVIRUS AGENT; INDOCYANINE GREEN; INTERFERON; LAMIVUDINE;

ADULT; AGE; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; GENDER; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROWAVE IRRADIATION; PRIORITY JOURNAL; RADIOFREQUENCY RADIATION; RECURRENCE RISK; RISK ASSESSMENT; STATISTICAL ANALYSIS; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TIME FACTORS;

EID: 10744230250     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1163-2     Document Type: Article

References (35)

1. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis. A prospective observation of 795 cases with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
2. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328:1797-801.
3. Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, et al. Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B. Hepatology 1995;21:77-82.
4. Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis. A prospective observation of 2215 patients. J Hepatol 1998;28:930-8.
5. Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999;85: 2132-7.
6. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000;15:1356-61.
7. Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology 1984;86:495-502.
8. Okuda K. Early detection of hepatocellular carcinoma. Hepatology 1986;6:729-38.
9. Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, et al. Natural history of minute hepatocellular carcinoma smaller than 3 cm complicating cirrhosis. A study in 22 patients. Gastroenterology 1986;90:289-98.
10. Lui WY, Chau GY, Loong CC, Tsay SH, Wu JC, King KL, et al. Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma. Arch Surg 1995;130:1090-7.
11. Nagashima I, Hamada C, Naruse K, Osada T, Nagao T, Kawano N, et al. Surgical resection for small hepatocellular carcinoma. Surgery 1996;119:40-5.
12. Sheen PC, Lee KT, Chen HY, Chen JS, Ker CG. Conservative hepatic resection for hepatocellular carcinoma of cirrhotic patients. Int Surg 1996;81:280-3.
13. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P. Prognostic factors affecting long-term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 1998;82:1028-36.
14. Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 2000;191:381-8.
15. Nagasue N, Ono T, Yamanoi A, Kohno H, El-Assal ON, Taniura H, et al. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 2001;88: 515-22.
16. Sugimoto R, Okuda K, Tanaka M, Aoyagi S, Kojiro M. Metachronous multicentric occurrence of hepatocellular carcinoma after surgical treatment - clinicopathological comparison with recurrence due to metastasis. Oncol Rep 1999;6:1303-8.
17. Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 1993;40:328-32.
18. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89:500-7.
19. Nakano S, Haratake J, Okamoto K, Takeda S. Investigation of resected multinodular hepatocellular carcinoma: assessment of unicentric or multicentric genesis from histological and prognostic viewpoint. Am J Gastroenterol 1994;89:189-93.
20. Kubo S, Kinoshita H, Hirohashi K, Tanaka H, Tsukamoto T, Hamba H, et al. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation. Hepatogastroenterology 1999;46:3212-5.
21. Oon CL. Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions. Cancer Chemother Pharmacol 1992;31(Suppl):S137-42.
22. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic acitive hepatitis C with cirrhosis. Lancet 1995;346:1051-5.
23. Mazzella G, Accogli E, Sottili S, Festi D, Orsini M, Salzetta A, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 1996;24:141-7.
24. Fattovich G, Giustina G, Realdi G, Corrocher R, Schalm SW. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis. Hepatology 1997; 26:1338-42.
25. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-72.
26. Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Fukuda M, et al. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus. Cancer 1998;82:827-35.
27. Lin SM, Sheen IS, Chien RN, Chu CM, Liaw YF. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999;29:971-5.
28. Ikeda K, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, et al. Long-term interferon therapy for one year or longer reduces hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus. A pilot study. J Gastroenterol Hepatol 2001;16:406-15.
29. Harrington DP, Fleming TR. A class of rank test procedures for censored survival data. Biometrica 1982;69:553-66.
30. Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457-81.
31. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34:248-75.
32. SPSS. SPSS for Windows version 11.0 manual. Chicago: SPSS; 2001.
33. Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis B. Hepatology 1996;24:307-10.
34. Yamamoto T, Kajino K, Kudo M, Sasaki Y, Arakawa Y, Hino O. Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA. Hepatology 1999;29:1446-52.
35. Maeda T, Takenaka K, Taguchi K, Kajiyama K, Shirabe K, Shimada M, et al. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas. Hepatogastroenterology 2000;47:498-503.